• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Prevalence of hs-CRP among Indians with hypertension
Bioinformation. 2022 Oct 31;18(10):1041-1043. doi: 10.6026/973206300181041. eCollection 2022.ABSTRACTThe prevalence of hypertension in the early twentieth century varied in India, ranging from 2-15% in Urban India and 2-8% in Rural India. In the inter heart and inter stroke study, hypertension accounted for 17.9% and 34.6% of population attributable risk for coronary artery disease and stroke respectively. CRP appears in serum in response to a variety of inflammatory stimuli .Raised level of hs-CRP is seen with increasing with age, during an infection, inflammation, coronary artery diseases, obesity, sepsis, smoking and va...
Source: Bioinformation - September 1, 2023 Category: Bioinformatics Authors: Vasanthii R Kaarthikeyan G Sasirekha G Mahalakshmi S Source Type: research

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
Bioinformation. 2021 Mar 31;17(3):413-423. doi: 10.6026/97320630017413. eCollection 2021.ABSTRACTIt is of interest to evaluate the clinical effectiveness and safety of vildagliptin as monotherapy and combination therapy of vildagliptin and metformin for the management of type 2 diabetes mellitus (T2DM) patients in Indian settings. The study included patients with T2DM (aged >18 years) receiving vildagliptin monotherapy and vildagliptin in combination with metformin therapy of various strengths. Data related to demographics, risk factors, medical history, glycated hemoglobin (HbA1c) levels, and medical therapies were ret...
Source: Bioinformation - June 7, 2021 Category: Bioinformatics Authors: Sambit Das A K Gupta Biplab Bandyopadhyaya B Harish Darla Vivek Arya Mahesh Abhyankar Santosh Revankar Source Type: research

Pages: 1  2  3